Search

Vaccination Schedule

By Sarah Gee
©Voice, May 2006

This is just a suggested schedule. Your veterinarian can put together a schedule tailored for your horse and your situation. Also note that many combination vaccines are offered. Again, consult your veterinarian.

Disease/Vaccine
Foals/Weanlings
Yearlings
Performance Horses
Pleasure Horses
Broodmares
Notes
Tetanus Toxoid
From nonvaccinated mares:1st dose: 3-4 months. 2nd dose: 4-5 months.

From vaccinated mares:1st dose: 6 months.
2nd dose: 7 months.3rd dose: 8-9 months.

Annual
Annual
Annual
Annual, 4 to 6 weeks prior to delivery.
If last dose not administered within 6 months give booster at time of penetrating injury or surgery.
Encephalomyelitis
(EEE, WEE, VEE)
EEE: (in high risk areas)
1st dose: 3-4 months. 2nd dose: 4-5 months.
3rd dose: 8-9 months

WEE, EEE, VEE: (in low risk areas)
From nonvaccinated mares:1st dose: 3-4 months. 2nd dose: 4-5 months. 3rd dose: 5-6 months. From vaccinated mares: 1st dose: 6 months. 2nd dose: 7 months. 3rd dose: 8 months.

Annual

 


Annual, Spring

Annual, Spring

 


Annual, Spring

Annual, Spring

 


Annual, Spring

Annual, 4 to 6 weeks prior to delivery.

 


Annual, 4-6 weeks prior to delivery.

In areas where disease is prevalent booster EEE and WEE every 6 months; VEE only when threat of exposure; VEE may only be available as a combination vaccine with EEE and WEE.
Influenza Inactivated injectible:
From nonvaccinated mares: 1st dose: 6 months. 2nd dose: 7 months. 3rd dose: 8 months.
Then at 3-month intervals.
From vaccinated mares: 1st dose: 9 months.
2nd dose 10 months. 3rd dose: 11-12 months.
Then at 3-mont intervals.
Every 3 to 4 months. Every 3 to 4 months. Annual with added boosters
prior to likely exposure.
At least semiannual,
with 1 booster 4 to 6 weeks prior to delivery.
A series of at least 3 dosses is recommended for primary immunization of foals.
Rhinopneumonitis
(EVH-1 and EVH-4)
1st dose: 4-6 months.
2nd dose: 5-7 months.
3rd dose: 6-8 months.
Then at 3-month intervals.
Booster every 3 to 4 months
up to annually.
Booster every 3 to 4 months
up to annually.
Optional: semi-annual if elected. 5th, 7th, 9th month of gestation (inactivated EVH-1 vaccine); optional dose at thrid month
of gestation.
Vaccination of mares before breeding and 4 to 6 weeks prior to delivery is suggested. Breeding stallions should be vaccinated before the breeding season and semiannually.
Strangles Injectable:
1st dose: 4-6 months. 2nd dose: 5-7 months.
3rd dose: 7 to 8 months.
4th dose: 12 months (depend on product used).

Intranasal:
1st dose: 6-9 months. 2nd dose: 3 weeks later.

Semi-annual Optional: semi-annual if risk
is high.
Optional: semi-annual if risk
is high.
Semi-annual with one dose of inactivated
M-protein vaccine 4 to 6 weeks prior to delivery.
Vaccines containing M-protein extract may be less reactive than whole-cell vaccines. Use when endemic conditions exist or risk is high. Foals as young as 6 weeks may safely receive the intranasal product. A 3rd dose should be given 2 to 4 weeks before weaning.
Potomac Horse Fever 1st dose: 5-6 months.
2nd dose: 6-7 months.
Semi-annual Semi-annual Semi-annual Semi-annual with 1 dose 4 to 6 weeks prior
to delivery.
Booster during May to June in areas where disease is common.
Botulism From nonvaccinated mare: See Notes

From vaccinated mare: 3-dose series of toxoid at 30-day intervals starting at 2 to 3 months of age.

Not applicable. Not applicable. Not applicable. Initial 3-dose series at 30-day intervals with
last dose 4 to 6 weeks prior to delivery.
Thereafter, annually, 4 to 6 weeks prior
to delivery.
Foal from nonvaccinated mare may benefit from: 1) toxoid at 2, 4, and 8 weeks of age; 2) transfusion of plasma from vaccinated horse; or 3) antitoxin. Efficacay needs further study.
Foals from vaccinated mares in endemic areas: A 3rd dose administered 4 to 6 weeks after the 2nd dose may improve the response of foals to primary immunization.
Rabies From nonvaccinated mares: 1st dose: 3-4 months. 2nd dose: 12 months.

From vaccinated mares: 1st dose: 6 months,
2nd dose: 7 months, 3rd dose: 12 months.

Annual Annual Annual Annual, before breeding Vaccination recommended in areas with high incidences of disease. Do not use modified-live-virus vaccines in horses
Equine Viral Arteritis Intact colts intended to be breeding stallions:
one dose at 6-12 months.
Annual for colts intended to be breeding stallions. Annual for colts intended to be breeding stallions. Annual for colts intended to be breeding stallions. Annual for seronegative, open mares before breding to carrier stallions: isolate mares for 21 days after breeding to carrier stallion Annual for breeding stallions and teasers, 28 days before start of breeding season; virus may be shed in semen for up to 21 days. Vaccinated mares do not develop clinical signs even though they become transiently infected and may shed virus for a short time.
Rotovirus A Little value to vaccinate foal becasue insufficient time to develop antibodies to protect during suseptible age. Not applicable. Not applicable. Not applicable. Vaccinate mares at 8th, 9th, and 10th month of gestation, each pregnancy. Passive transfer of colostral antibodies aid in prevention of rotaviral diarrhea in foals. Check concentrations of immunoglobulins in foal to be assured that there is no failure of passive transfer.
West Nile 1st dose: 3-4 months.
2nd dose: 1 month later (plus 3rd dose at 6 months in areas where disease is common).
Annual booster, prior to expected risk. Vaccinate semi-annually or more frequently (every 4 months) depending on risk. Annual booster, prior to expected risk. Vaccinate semi-annually or more frequently (every 4 months) depending on risk. Annual booster, prior to expected risk. Vaccinate semi-annually or more frequently (every 4 months) depending on risk. Annual, 4 to 6 weeks prior to delivery
(consult veterinarian).
Annual booster is after primary series. In areas with frequent West Nile occuraces, booster as required or warranted due to local conditions conducive to disease risk. Vaccinate semi-annually or more frequently (every 4 months), depending on risk.

Source: American Association of Equine Practitioners

 



© 1996-2008 Tennessee Walking Horse Breeders' and Exhibitors' Association. All Rights Reserved.
Terms And Conditions Of Use
Privacy Policy